HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 22, Issue 12, Pages 581-590
Publisher
Springer Nature
Online
2015-10-23
DOI
10.1038/cgt.2015.55
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity
- (2015) Janani Panneerselvam et al. Oncotarget
- IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis
- (2015) Janani Panneerselvam et al. PLoS One
- Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells
- (2014) Norah Al-Souhibani et al. CARCINOGENESIS
- Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells
- (2014) Anish Babu et al. MOLECULAR PHARMACEUTICS
- Expression of the ELAV-like protein HuR in the cytoplasm is associated with endometrial carcinoma progression
- (2014) Dandan Wang et al. TUMOR BIOLOGY
- Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis
- (2013) Jun Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Halting metastasis through CXCR4 inhibition
- (2012) Deborah M. Ramsey et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer
- (2012) Lei Liu et al. Cancer Epidemiology
- Inhibition of stromal CXCR4 impairs development of lung metastases
- (2012) Crescenzo D’Alterio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of novel CXCR4-based therapeutics
- (2012) Amnon Peled et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HuR function in disease
- (2011) Subramanya Srikantan Frontiers in Bioscience-Landmark
- CXCR4 Overexpression Is Associated with Poor Outcome in Females Diagnosed with Stage IV Non-small Cell Lung Cancer
- (2011) Shannon Otsuka et al. Journal of Thoracic Oncology
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases
- (2010) Daisuke Uchida et al. EUROPEAN JOURNAL OF CANCER
- Posttranscriptional regulation of cancer traits by HuR
- (2010) Kotb Abdelmohsen et al. Wiley Interdisciplinary Reviews-RNA
- Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung
- (2009) Yoshihiro Minamiya et al. LUNG CANCER
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- (2008) B. Nervi et al. BLOOD
- The role of CXC chemokines and their receptors in cancer
- (2008) Jo Vandercappellen et al. CANCER LETTERS
- Nuclear expression of CXCR4 in tumor cells of non–small cell lung cancer is correlated with lymph node metastasis
- (2008) Il-Kang Na et al. HUMAN PATHOLOGY
- CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival
- (2008) Patrick L. Wagner et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now